Ginkgo Bioworks Holdings Inc (NYSE:DNA) does about 51.66M shares in volume on a normal day but saw 224512470 shares change hands in Friday trading. The company now has a market cap of 699.11M USD. Its current market price is $0.33, marking an increase of 8.12% compared to the previous close of $0.31. The 52 week high reached by this stock is $2.55 whilst the lowest price level in 52 weeks is $0.26.
Ginkgo Bioworks Holdings Inc (DNA) has a 20-day trading average at $0.4464 and the current price is -86.86% off the 52-week high compared with 26.53% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.6679 and its 200-day simple moving average is $1.2304. If we look at the stock’s price movements over the week, volatility stands at 18.40%, which decreases to 10.99% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 27.95 to suggest the stock is oversold.
The consensus objective for the share price is $1.16, suggesting that the stock has a potential upside of 71.55% over the period.
Raymond James downgraded its price target at $3.50-$2.50.
Ginkgo Bioworks Holdings Inc (DNA) stock is down -21.23% over the week and -40.38% over the past month. Its price is -80.22% year-to-date and -81.63% over the past year.
To reach the target analysts have set, the stock logically needs to grow 71.55 percent from here.
The company has a return on investment of -69.88% and return on equity of -65.81%. The beta has a value of 1.11. Price to book ratio is 0.65 and price to sales ratio is 3.35.
